Rebecca Vanderpool, PhD

4.3K posts

Rebecca Vanderpool, PhD banner
Rebecca Vanderpool, PhD

Rebecca Vanderpool, PhD

@RRVdpool

A biomedical engineer researching right ventricular function and pulmonary vascular disease. Opinions are mine. @rrvdpool@med-mastodon

Columbus, OH Katılım Ocak 2017
919 Takip Edilen1.4K Takipçiler
Rebecca Vanderpool, PhD retweetledi
ATS PC Assembly
ATS PC Assembly@ATS_PC·
Shoutout to the early career members of @ATS_PC! 🎉From bench to bedside, you're pushing the boundaries of pulmonary vascular science every single day. Today, we are highlighting Dr. Yogeswaran:
ATS PC Assembly tweet media
English
1
1
9
284
Rebecca Vanderpool, PhD retweetledi
ATS_Assemblies
ATS_Assemblies@ATS_Assemblies·
If you are part of the @ATS_PC we hope to see you at the Membership Meeting from 5pm to 7pm in W307 (Level III, OCCC, West Concourse) !
English
0
2
4
229
Rebecca Vanderpool, PhD retweetledi
ATS PC Assembly
ATS PC Assembly@ATS_PC·
Are you tired of carrot sticks and long PowerPoint presentations at ATS assembly meetings? 😴 Instead, get to know your @ATS_PC community with our inaugural networking bingo and win a tantalizing 🏆! ⏰Mon May 18 5-7pm EST @atsearlycareer @atscommunity @SueGuMD
English
0
1
3
230
Rebecca Vanderpool, PhD retweetledi
ATS PC Assembly
ATS PC Assembly@ATS_PC·
We’re spoilt for choice this morning with all the #PC sessions at #ATS2026! 🤩 Drs. Al-Namaani, Saggar, and Ghofrani are keeping us on ⏰as we learn about the latest clinical trials and real-world data:
ATS PC Assembly tweet mediaATS PC Assembly tweet media
English
0
4
9
523
Rebecca Vanderpool, PhD retweetledi
Navneet Singh, MD, ScM
Navneet Singh, MD, ScM@navneetsinghmd·
#ATS2026 can be overwhelming but the @ATS_PC Early Career Working Group is here to save the day again! This roadmap is such a helpful guide to the meeting. @RRVdpool @PennMedPH @BrownPVD
ATS PC Assembly@ATS_PC

#ATS2026 is finally here! As you travel & prepare, don't miss our @ATS_PC EC Working Group Roadmap - your🌟guide to all things #PH #PVD #PulmCirc! @SueGuMD @navneetsinghmd @rjbernardoMD @MaryamSanjani @RRVdpool @chansteve73 @SashaPrisco @atsearlycareer atspcecwg.my.canva.site/ats-2026-ecwg-…

English
0
2
6
447
Rebecca Vanderpool, PhD retweetledi
Kathryn del Valle
Kathryn del Valle@kdelvalleMD·
📢📢 Calling all PHriends heading to #ATS2026: Don't miss this Pulmonary Circulation Networking Event -- Early/Mid-career folks particularly encouraged to attend. UT medical affairs will also be there to discuss IIS grant mechanisms and project ideas.
Kathryn del Valle tweet media
English
0
2
4
205
Rebecca Vanderpool, PhD retweetledi
AHA Science
AHA Science@AHAScience·
Right ventricular (RV) dysfunction is a key determinant of outcomes in pulmonary hypertension and is increasingly recognized in other conditions, including heart failure with preserved ejection fraction, congenital heart disease, cardiomyopathies, acute infection, critical illness, and after left ventricular assist device implantation. Therapeutic strategies are increasingly shifting toward RV–targeted approaches, such as modulation of inflammation, fibrosis, metabolism, and RV-pulmonary artery (PA) uncoupling coupling, highlighting the need for RV–specific endpoints in clinical trials. ✍🏼 @PullamsettiL @sbonnet2 @RRVdpool @Viniciodjperez 📷 Mechanisms driving right ventricular dysfunction in pulmonary hypertension.
AHA Science tweet media
English
1
33
68
4.7K
Rebecca Vanderpool, PhD retweetledi
AHA Science
AHA Science@AHAScience·
In pulmonary hypertension (PH), chronic pressure overload can progress from adaptive right ventricular (RV) hypertrophy to maladaptive remodeling, characterized by RV dilation, fibrosis, stiffness, and RV–pulmonary artery uncoupling. This statement summarizes current knowledge on RV dysfunction in PH, emphasizing its mechanisms, clinical relevance, and therapeutic potential. ✍🏼 @PullamsettiL @sbonnet2 @RRVdpool @Viniciodjperez
AHA Science tweet media
English
2
37
105
9.6K
Jason Hong, MD, PhD
Jason Hong, MD, PhD@jasonhongFC·
Provocative discussion at #AHA25 on “Inflammation in Preclinical vs. Clinical PAH” — exploring whether inflammation is a true therapeutic target or just a bystander in PAH. @3CPRCouncil
Jason Hong, MD, PhD tweet media
English
1
3
9
2.1K
Yuanjun Shen (Steve)
Yuanjun Shen (Steve)@YuanjunS·
What an experience in submitting my first R01! Sincerely appreciate all the support from my collaborators, colleagues, lab members, my department and the university! My thanks also extend to my husband, my extend family and my pets❤️
Yuanjun Shen (Steve) tweet media
English
1
0
5
290
Rebecca Vanderpool, PhD retweetledi
ATS_Assemblies
ATS_Assemblies@ATS_Assemblies·
The 21st Robert Grover Conference brought together investigators in Colorado to advance lung vascular biology + medicine. Since 1984, this biennial meeting has inspired cross-generational collaboration in a unique, secluded setting. 🌄🫁#groverconference
ATS_Assemblies tweet media
English
1
8
16
1.4K
Rebecca Vanderpool, PhD retweetledi
The ISHLT
The ISHLT@ISHLT·
📢 A NEW #ISHLT Consensus Statement on risk stratification in pulmonary arterial hypertension (#PAH) is now available. 📖 Check out the top 5️⃣ takeaways ⏬ & read the publication at 🔗 bit.ly/4lXTrLd
The ISHLT tweet mediaThe ISHLT tweet media
English
1
22
47
5.4K